FundedIQ
Biotechnology

Aerin Medical: Funding, Investors & Team (Sep 2026)

Aerin Medical is a company focused on health technology, creating therapeutic devices that aim to enhance nasal breathing. Using low-power radiofrequency energy, their device works to reshape the soft tissues in the nose and target the root cause of nasal congestion. Their products, VivAer and RhinAer, target nasal airway obstruction and chronic rhinitis, respectively, and utilize their unique temperature-controlled technology. This allows ENT physicians to effectively improve patients' symptoms without the need for invasive surgery, offering a more attractive option for treatment.

www.aerinmedical.com LinkedIn Mountain View, United States 101-250 employees
Biotechnology Health Care Medical Device Therapeutics
Total raised
$115M
Rounds
3
Latest
Undisclosed round
Jan 2025

Aerin Medical has raised $115M across 3 funding rounds on record, the most recent an undisclosed round of $32.5M announced in Jan 2025.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Aerin Medical Company Profile and Key Stats

Total funding raised
$115M
across 3 rounds on record
Funding rounds on record
3
Latest funding round
Undisclosed round
$32.5M in Jan 2025
Employees
101-250
reported band
Headquarters
Mountain View, United States

Latest funding round on record: Jan 2025.

Aerin Medical Funding Rounds

Date
Round
Amount
Undisclosed round
$32.5M
Undisclosed round
$34.9M
Undisclosed round
$48.0M

Aerin Medical raised $48.0M in an undisclosed round announced in Aug 2020.

1.8 years later, an undisclosed round of $34.9M was announced in May 2022.

2.7 years later, an undisclosed round of $32.5M was announced in Jan 2025.

Aerin Medical Founders and Leadership Team

Name
Role
Contact
Scott J Wolf
Founder
Fred Dinger
CEO
Locked
Matt Brokaw
CEO
Locked

Contact details for the Aerin Medical team: 2 of 3 have an email address on file.

Start 14-day free trial →

Aerin Medical Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Aerin Medical's latest round of $32.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Aerin Medical in Biotechnology and Mountain View

Companies Similar to Aerin Medical

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Aerin Medical Funding FAQs

What does Aerin Medical do?

Aerin Medical is a company focused on health technology, creating therapeutic devices that aim to enhance nasal breathing. Using low-power radiofrequency energy, their device works to reshape the soft tissues in the nose and target the root cause of nasal congestion. Their products, VivAer and RhinAer, target nasal airway obstruction and chronic rhinitis, respectively, and utilize their unique temperature-controlled technology. This allows ENT physicians to effectively improve patients' symptoms without the need for invasive surgery, offering a more attractive option for treatment.

How much funding has Aerin Medical raised?

Aerin Medical has raised $115M across 3 rounds on record. The most recent is an undisclosed round of $32.5M announced in Jan 2025.

When did Aerin Medical last raise funding?

Aerin Medical's most recent funding round on record is an undisclosed round of $32.5M, announced in Jan 2025.

Who founded Aerin Medical?

FundedIQ lists Scott J Wolf (Founder) at Aerin Medical.

Who is the CEO of Aerin Medical?

Fred Dinger is listed as CEO at Aerin Medical.

Where is Aerin Medical headquartered?

Aerin Medical is based in Mountain View, California, United States.

How many employees does Aerin Medical have?

Aerin Medical is in the 101-250 employee band.

How does Aerin Medical's funding compare to other Biotechnology startups?

Aerin Medical's latest round of $32.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Aerin Medical Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aerin Medical is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.